Search for: "v. Teva Pharmaceuticals USA, Inc." Results 401 - 420 of 445
Sorted by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
8 Feb 2008, 7:00 pm
– Facebook’s contractual rights to users’ photos problematic: (Spicy IP)PharmaEuropean Commission probes pharmaceutical sector: (Philip Brooks),WHO Board sets course on IP, avian flu, tighter publication policy: (Intellectual Property Watch),India: The Competition Act, patents and over hyped drugs: (Part I - Spicy IP), (Part II – Spicy IP), (Part III – Spicy IP),Ignoring not the solution … [read post]
28 May 2010, 11:51 pm
USA, Inc., 418 F.3d 1326, 1348 (Fed. [read post]
28 Sep 2015, 9:07 am by Jason Rantanen
Teva Pharmaceuticals USA, Inc., 549 Fed. [read post]
13 Dec 2018, 11:16 am by Adam Feldman
Teva Pharmaceuticals USA Inc., which asks: “Whether, under the Leahy-Smith America Invents Act, an inventor’s sale of an invention to a third party that is obligated to keep the invention confidential qualifies as prior art for purposes of determining the patentability of the invention. [read post]
31 Mar 2010, 1:58 pm
Teva Pharm., USA, Inc., 429 F.3d 1364, 1377 (Fed. [read post]
23 Oct 2009, 4:12 pm
Teva Pharmaceuticals USA, Inc. and related cases) (2009 U.S. [read post]
4 Apr 2008, 1:00 am
: (IPBiz) Pharma & Biotech - Products Abilify (Aripiprazole) – Otsuka files US patent infringement suit against Teva over seeking approval for generic Abilify: (IP Law360), Aricept (Donepezil) – US federal judge grants Eisai’s request for preliminary injunction blocking Teva from marketing generic version of Aricept: (IP Law360), (Orange Book Blog), Carbatrol (Carbamazepine) – US federal judge delivers mixed ruling in… [read post]
18 Jul 2008, 8:34 am
: (Patent Circle), Tanzania to conduct study on impact of counterfeit medicines: (Afro-IP), US: New rules on generic biological medicines under US Congressional debate: (Intellectual Property Watch), Pharma & Biotech - Products Acular (Ketorolac) – US: CAFC rules against Apotex reverse doctrine of equivalents: Roche Palo Alto & Allergan, Inc v Apotex: (Patent Circle), Carbatrol (Carbamazapine) – US: Federal judge allows Corepharma to seek DJ… [read post]
21 May 2019, 6:18 am by Elizabeth McCuskey
They can be “subsumed within an already tightly circumscribed legal analysis,” as the court recently explained in the patent-construction context in Teva Pharmaceuticals USA Inc. v. [read post]
21 Oct 2014, 9:03 am by Dennis Crouch
Teva Pharmaceuticals USA, Inc., the Federal Circuit panel affirmed a lower court finding that BMS’s patent covering the Hep-B drug entecavir is invalid as obvious. [read post]
7 Jun 2011, 12:30 pm by Christa Culver
Certiorari stage documents:Opinion below (2d Circuit)Petition for certiorariBrief in opposition of Steinbeck Heritage Foundation/Estate RespondentsPetitioners' replyAmicus brief of Graphic Artists Guild et al.Amicus brief of Penguin Group (USA), Inc. [read post]
21 Apr 2011, 1:36 pm by Bexis
Teva Pharmaceuticals USA, Inc., 2007 WL 5787186 (S.D. [read post]
23 Jan 2019, 4:07 am by Edith Roberts
” For USA Today, Richard Wolf reports that by agreeing to hear the New York gun case, New York State Rifle & Pistol Association Inc. v. [read post]
7 Dec 2023, 1:47 pm by Dennis Crouch
Teva Pharmaceuticals USA, Inc., 7 F.4th 1320, 1333 (Fed. [read post]
21 Jun 2018, 4:00 pm by Aurora Barnes
Teva Pharmaceuticals USA Inc. 17-1229 Issue: Whether, under the Leahy-Smith America Invents Act, an inventor’s sale of an invention to a third party that is obligated to keep the invention confidential qualifies as prior art for purposes of determining the patentability of the invention. [read post]